News

Polares Medical Closes a $40M Financing to Complete Pilot Clinical Studies

Polares Medical Closes a $40M Financing to Complete Pilot Clinical Studies Lausanne & Palo Alto, June 25, 2020. Polares Medical SA, a clinical-stage medical technology company focused on the development of a unique trans-catheter mitral valve hemi-replacement system to treat patients suffering from mitral regurgitation (MR), announced today [...]

2020-07-06T15:20:30+01:00June 26th, 2020|All News, Blog|

Sonata System assists facilities impacted by the COVID-19 pandemic in restarting elective gynecologic procedures

Sonata® System assists facilities impacted by the COVID-19 pandemic in restarting elective gynecologic procedures Positive aspects of transcervical fibroid ablation, strong clinical results, provides facilities with confidence in treating fibroids and minimizing potential viral risks – procedural volumes increasing Redwood City, CA – June 22, 2020 – Gynesonics®, [...]

2020-06-22T17:29:53+01:00June 22nd, 2020|All News, Blog|

Relievant announces publication of 5-Year data demonstrating long-term clinical benefits of the Intracept procedure in chronic low back pain patients

Relievant announces publication of 5-Year data demonstrating long-term clinical benefits of the Intracept procedure in chronic low back pain patients MINNEAPOLIS, June 08, 2020 (GLOBE NEWSWIRE) -- Relievant Medsystems, a privately-held medical device company transforming the treatment of Chronic Low Back Pain (CLBP), today announced European Spine Journal [...]

2020-06-08T17:33:59+01:00June 8th, 2020|All News, Company News|

Gynesonics announces publications on healthcare economic analyses demonstrating significant facility and payer cost savings

Gynesonics announces publications on healthcare economic analyses demonstrating significant facility and payer cost savings when performing the sonata treatment compared to hysterectomy and myomectomy for symptomatic fibroids The Sonata System provides advantages in reducing the index procedure cost, length of stay (LOS), prescription medications, complications and radiology costs [...]

2020-06-08T17:09:47+01:00June 8th, 2020|All News, Blog|

Impact of COVID-19 on medtech innovation investing

Impact of COVID-19 on medtech innovation investing 08 June, 2020 Bernard Vogel, Managing Partner at Endeavour Vision The medtech industry has never in history been of such pivotal importance as in the last few months during the pandemic. As countries all over the world grappled with the devastating [...]

2020-06-10T09:19:42+01:00June 8th, 2020|All News, Blog|

Gynesonics receives FDA clearance to market next generation Sonata® System 2.1

Gynesonics receives FDA clearance to market next generation Sonata® System 2.1 Early launch in Europe contributes to significant procedural growth Redwood City, CA – May 28, 2020 – Gynesonics, a women’s healthcare company focused on the development of minimally-invasive solutions for symptomatic uterine fibroids, announced today that it [...]

2020-05-29T11:55:11+01:00May 29th, 2020|All News, Blog|

Rapid Micro Biosystems Raises $120 Million to Accelerate Global Expansion of Contaminant Testing Platform for Pharmaceutical and Vaccine Manufacturing

Rapid Micro Biosystems Raises $120 Million to Accelerate Global Expansion of Contaminant Testing Platform for Pharmaceutical and Vaccine Manufacturing Proceeds will enable the company to meet growing demand for its automated microbial detection platform, currently used by a majority of the top 20 global biopharmaceutical companies, and support [...]

2020-05-20T12:42:46+01:00May 20th, 2020|All News, Blog|

Molecular Partners Confirms Ultra-Potent Inhibition of SARS-CoV-2 Live Virus by Anti-COVID-19 DARPin® Candidates

Molecular Partners Confirms Ultra-Potent Inhibition of SARS-CoV-2 Live Virus by Anti-COVID-19 DARPin® Candidates DARPin® antiviral candidates demonstrate low picomolar potency in live virus assay Candidate construction complete; two candidates ready for preclinical development & manufacturing Therapeutic profile of a highly potent antiviral biologic with a long half-life supports [...]

2020-05-14T11:19:01+01:00May 14th, 2020|All News, Blog|

Endeavour Vision interview with AGEFI – Impact of COVID-19 on investments in starts-ups, the medtech sector and the firm’s investment strategy

Endeavour Vision's Co-Founder and Managing Partner, Bernard Vogel, spoke to the Swiss news publication, AGEFI, to share his insights on the impact of COVID-19 on Swiss start-ups, the med tech sector and the firm's investment strategy. Scroll down for the English translation. Published in AGEFI on 20 April, [...]

2020-04-27T17:57:13+01:00April 27th, 2020|All News, Blog|
Go to Top